Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Provention Bio Inc (PRVB)  
$24.98 0.00 (0.00%) as of 4:30 Wed 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 63,632,000
Market Cap: 1.59(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $24.98 - $24.98
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Provention Bio is a biopharmaceutical company. Co.'s pipeline of investigational candidates under development includes: PRV-031 (teplizumab), an anti-CD3 monoclonal antibody (mAb) for the delay of clinical Type 1 Diabetes (T1D); PRV-3279, a bispecific scaffold molecule targeting the B-cell surface proteins, FcgammaRIIb and CD79B, for the treatment of systemic lupus erythematosus; PRV-015 (ordesekimab), an anti-interleukin 15 mAb for the treatment of gluten-free diet non-responsive celiac disease; and PRV-101, a Coxsackie Virus B (CVB) vaccine to prevent acute CVB infections and to prevent the CVB-triggered autoimmune damage to pancreatic beta cells that may progress to T1D.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 5,594,666
Total Sell Value $0 $0 $0 $85,590,128
Total People Sold 0 0 0 4
Total Sell Transactions 0 0 0 13
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 94
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Petry John 10% Owner   –       –       •   2023-04-27 4 D $0.00 $0 D/D (15,567,497) 0     -
   Ramos Eleanor Chief Medical Officer   •       –      –    2023-04-27 4 D $0.00 $0 D/D (70,000) 0     -
   Leon Francisco Chief Scientific Officer   •       –      –    2023-04-27 4 D $0.00 $0 I/I (2,500,000) 0     -
   Leon Francisco Chief Scientific Officer   •       –      –    2023-04-27 4 D $0.00 $0 D/D (73,000) 0     -
   Pisano Wayne Director   –       •      –    2023-04-27 4 D $0.00 $0 D/D (7,500) 0     -
   Catlin Avery W Director   –       •      –    2023-04-27 4 D $0.00 $0 I/I (20,000) 0     -
   Palmer Ashleigh Director and CEO   •       –      –    2023-04-27 4 D $0.00 $0 D/D (2,570,050) 0     -
   Petry John 10% Owner   –       –       •   2023-04-21 4 GD $0.00 $0 D/D 224,617 0     -
   Petry John 10% Owner   –       –       •   2023-04-20 4 GD $0.00 $0 D/D 202,314 224,617     -
   Petry John 10% Owner   –       –       •   2023-04-14 4 S $24.32 $53,274,152 D/D (2,190,549) 15,567,497 -3%     
   Petry John 10% Owner   –       –       •   2023-04-14 4 OE $6.00 $53,274,138 D/D 8,879,023 17,758,046     -
   Catlin Avery W Director   –       •      –    2023-04-13 4 GA $0.00 $0 I/I 10,000 10,000     -
   Catlin Avery W Director   –       •      –    2023-04-13 4 GD $0.00 $0 D/D 10,000 10,000     -
   Leon Francisco Chief Scientific Officer   •       –      –    2023-04-13 4 GA $0.00 $0 I/I 1,500,000 73,000     -
   Leon Francisco Chief Scientific Officer   •       –      –    2023-04-13 4 GD $0.00 $0 D/D 1,500,000 73,000     -
   Palmer Ashleigh Director and CEO   •       •      –    2023-02-13 4 AS $10.04 $259,448 D/D (25,835) 2,570,050 152%     
   Palmer Ashleigh Director and CEO   •       •      –    2023-02-13 4 OE $2.50 $64,588 D/D 25,835 2,595,885     -
   Leon Francisco Chief Scientific Officer   •       –      –    2023-02-13 4 AS $10.04 $260,944 D/D (25,985) 1,573,000 152%     
   Leon Francisco Chief Scientific Officer   •       –      –    2023-02-13 4 OE $2.50 $64,963 D/D 25,985 1,598,985     -
   Palmer Ashleigh Director and CEO   •       •      –    2023-02-10 4 AS $10.11 $505,555 D/D (50,000) 2,570,050 140%     
   Palmer Ashleigh Director and CEO   •       •      –    2023-02-10 4 OE $2.50 $125,000 D/D 50,000 2,620,050     -
   Hoitt Jason Chief Commercial Officer   •       –      –    2023-02-10 4 AS $10.00 $45,005 D/D (4,500) 0 140%     
   Leon Francisco Chief Scientific Officer   •       –      –    2023-02-10 4 AS $10.11 $505,605 D/D (50,000) 1,573,000 140%     
   Leon Francisco Chief Scientific Officer   •       –      –    2023-02-10 4 OE $2.50 $125,000 D/D 50,000 1,623,000     -
   Petry John 10% Owner   –       –       •   2023-01-18 4 S $9.40 $28,200,000 D/D (3,000,000) 11,879,023 -177%     
  94 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us